首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEPATITIS, LIVER CIRRHOSIS, OR LIVER CNACER COMPRISING AMINOQUINOLONE DERIVATIVES

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEPATITIS, LIVER CIRRHOSIS, OR LIVER CNACER COMPRISING AMINOQUINOLONE DERIVATIVES

机译:预防或治疗包含氨基喹诺酮衍生物的肝炎,肝硬化或肝硬化的药物组合物

摘要

the invention Hepatitis C virus (Hepatitis C virus, HCV) for indicating excellent anti-proliferative efficacy aminoquinoline compound , a pharmaceutically acceptable salt thereof , or a hydrate thereof and a preparation method thereof , and hepatitis containing the same as an active ingredient , cirrhosis , or a pharmaceutical composition for the prevention or treatment of liver cancer , and relates to an antiviral composition for HCV the aminoquinoline compound according to the present invention , a pharmaceutically acceptable salt thereof , or hydrate exhibits low cell toxicity Possession excellent HCV inhibitory activity and anti-proliferative effects , inhibition of hepatitis C virus as well as further C- hepatitis , cirrhosis , liver cancer , such as may be useful for the prevention or treatment of various liver diseases .
机译:本发明的丙型肝炎病毒(丙型肝炎病毒,HCV),用于表现出优异的抗增殖功效,氨基喹啉化合物,其药学上可接受的盐或其水合物及其制备方法,以及以其为有效成分的肝炎,肝硬化,或用于预防或治疗肝癌的药物组合物,并且涉及用于HCV的抗病毒组合物,本发明的氨基喹啉化合物,其药学上可接受的盐或具有低细胞毒性的水合物具有极好的HCV抑制活性和抗增殖作用,抑制丙型肝炎病毒以及进一步的丙型肝炎,肝硬化,肝癌等可能对预防或治疗各种肝病有用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号